Vemurafenib may overcome TNF-related apoptosis-inducing ligand (TRAIL) resistance in anaplastic thyroid cancer cells.
Saved in:
| Title: | Vemurafenib may overcome TNF-related apoptosis-inducing ligand (TRAIL) resistance in anaplastic thyroid cancer cells. |
|---|---|
| Authors: | Pilli T; Department of Medical and Surgical Sciences and Neurosciences, University of Siena, Siena, Italy., Cantara S; Department of Medical and Surgical Sciences and Neurosciences, University of Siena, Siena, Italy., Marzocchi C; Department of Medical and Surgical Sciences and Neurosciences, University of Siena, Siena, Italy., Pacini F; Department of Medical and Surgical Sciences and Neurosciences, University of Siena, Siena, Italy., Prabhakar BS; Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL, USA., Castagna MG; Department of Medical and Surgical Sciences and Neurosciences, University of Siena, Siena, Italy. m.g.castagna@ao-siena.toscana.it. |
| Source: | Endocrine [Endocrine] 2020 Jan; Vol. 67 (1), pp. 117-123. Date of Electronic Publication: 2019 Aug 03. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9434444 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-0100 (Electronic) Linking ISSN: 1355008X NLM ISO Abbreviation: Endocrine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
